{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:53:29Z","timestamp":1773939209754,"version":"3.50.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Although the prognosis in systemic lupus erythematosus (SLE) has dramatically improved, pulmonary artery hypertension (PAH) is one of the life-threatening comorbidities associated with SLE. The management of the comorbidity is occasionally challenging due to the lack of consensus regarding treatment options including immunosuppressive agents, selective pulmonary vasodilators, and cardiac rehabilitation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 28-year-old female who terminated prednisolone after remission of SLE by her own discretion 3 years ago developed dyspnoea on effort. Transthoracic echocardiography showed dilatation of the right atrium (RA) and ventricle (RV), as well as the RV dysfunction. The findings of right heart catheterization and pulmonary perfusion scintigraphy confirmed PAH associated with connective tissue disease. According to the SLE Disease Activity Index (SLEDAI) and the REVEAL Registry Risk Score, she was at high risk of PAH despite mild SLE activity. Upfront combination therapy including macitentan and tadalafil for PAH and steroid semi-pulse and cyclophosphamide pulse therapy for SLE alongside supervised cardiac rehabilitation were initiated simultaneously. The RA and RV sizes were normalized after the aforementioned therapy. The RV\u2013pulmonary artery (PA) coupling improved from 0.15 to 0.77\u2005mm\/mmHg, and the mean PA pressure decreased from 55 to 29\u2005mmHg.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The case presentation highlighted the potential benefits of comprehensive treatment strategy including immunosuppressive treatment, upfront combination therapy, and supervised exercise training. Notably, the initiation of cardiac rehabilitation at the early phase did not exacerbate her condition and might have contributed to remission of symptoms and improvement in exercise tolerance. This multidisciplinary approach achieved long-term good quality of life.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytae611","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T11:23:04Z","timestamp":1731669784000},"source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive treatment strategy in a patient with systemic lupus erythematosus-related pulmonary artery hypertension: a case report"],"prefix":"10.1093","volume":"9","author":[{"given":"Miku","family":"Yokoe","sequence":"first","affiliation":[{"name":"Department of Clinical Training Center, Seirei Mikatahara General Hospital , 3453 Mikatahara-cho, Chuo Ward, Hamamatsu, Shizuoka 433-8558 ,","place":["Japan"]},{"name":"Division of Cardiology, Department of Medicine, Showa University School of Medicine , 1-5-8 Hatanodai, Shinagawa Ward, Tokyo 142-8555 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7914-8256","authenticated-orcid":false,"given":"Satoshi","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Showa University School of Medicine , 1-5-8 Hatanodai, Shinagawa Ward, Tokyo 142-8555 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7349-7538","authenticated-orcid":false,"given":"Toshiro","family":"Shinke","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Showa University School of Medicine , 1-5-8 Hatanodai, Shinagawa Ward, Tokyo 142-8555 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"2025012113100129000_ytae611-B1","doi-asserted-by":"crossref","first-page":"924766","DOI":"10.3389\/fimmu.2022.924766","article-title":"The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus","volume":"13","author":"Qiu","year":"2022","journal-title":"Front Immunol"},{"key":"2025012113100129000_ytae611-B2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00002281-200109000-00002","article-title":"Mortality and causes of death in systemic lupus erythematosus","volume":"13","author":"Trager","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"2025012113100129000_ytae611-B3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"2025012113100129000_ytae611-B4","doi-asserted-by":"crossref","first-page":"1800332","DOI":"10.1183\/13993003.00332-2018","article-title":"ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension","volume":"53","author":"Gr\u00fcnig","year":"2019","journal-title":"Eur Respir J"},{"key":"2025012113100129000_ytae611-B5","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.106.618397","article-title":"Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension","volume":"114","author":"Mereles","year":"2006","journal-title":"Circulation"},{"key":"2025012113100129000_ytae611-B6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1378\/chest.12-0993","article-title":"Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension","volume":"143","author":"Chan","year":"2013","journal-title":"Chest"},{"key":"2025012113100129000_ytae611-B7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"2025012113100129000_ytae611-B8","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2025012113100129000_ytae611-B9","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"2025012113100129000_ytae611-B10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13075-024-03298-6","article-title":"Effect of remission, clinical remission with active serology, and glucocorticoid dosage on the pregnancy outcome of pregnant patients with systemic lupus erythematosus","volume":"26","author":"Nakai","year":"2024","journal-title":"Arthritis Res Ther"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytae611\/60680152\/ytae611.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/1\/ytae611\/60680152\/ytae611.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/1\/ytae611\/60680152\/ytae611.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T13:10:42Z","timestamp":1737465042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytae611\/7900802"}},"subtitle":[],"editor":[{"given":"Massimo","family":"Mapelli","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Marianna","family":"Garcia-Saldivia","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Nuzzi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Spinthakis","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytae611","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,11,15]]},"article-number":"ytae611"}}